Pharmacological inhibition of JAK3 enhances the antitumor activity of imatinib in human chronic myeloid leukemia

Kenta Yagi, Akira Shimada, Toshiaki Sendo

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Pharmacological inhibition of JAK3 enhances the antitumor activity of imatinib in human chronic myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences